Old Web
English
Sign In
Acemap
>
authorDetail
>
Mary Kathryn Smith
Mary Kathryn Smith
Takeda Pharmaceutical Company
Virology
Dengue vaccine
Immunology
Placebo
Adverse effect
2
Papers
88
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
2016
The Journal of Infectious Diseases
Chukiat Sirivichayakul
Elizabeth A. Barranco-Santana
Inés Esquilin-Rivera
Helen M. L. Oh
Marsha Raanan
Carlos A. Sariol
Lynette Pei-Chi Shek
Sriluck Simasathien
Mary Kathryn Smith
Iván Darío Vélez
Derek Wallace
Gilad Gordon
Dan T. Stinchcomb
Show All
Source
Cite
Save
Citations (48)
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study.
2015
Vaccine
Richard Rupp
Gary J. Luckasen
Judith Lee Kirstein
Jorge E. Osorio
Joseph D. Santangelo
Marsha Raanan
Mary Kathryn Smith
Derek Wallace
Gilad Gordon
Dan T. Stinchcomb
Show All
Source
Cite
Save
Citations (40)
1